In one paragraphArticle in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Namfa SermkaewSchool of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat 80160, Thailand.ORCID 0000-0002-0215-6506 Apichart AtipairinSchool of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat 80160, Thailand.
Sucheewin KrobthongCenter of Excellence in Natural Products Chemistry (CENP), Department of Chemistry, Faculty of Science, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.ORCID 0000-0003-4428-4140 Chanat AonbangkhenCenter of Excellence in Natural Products Chemistry (CENP), Department of Chemistry, Faculty of Science, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.ORCID 0000-0002-7378-1341 Yodying YingchutrakulNational Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Khlong Luang, Pathum Thani 12120, Thailand.ORCID 0000-0003-0701-4205 Jumpei UchiyamaDepartment of Infectious Diseases, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.ORCID 0000-0003-0846-0100 Nuttapon SongnakaSchool of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat 80160, Thailand.ORCID 0000-0003-3333-1730 Funding
Walailak University's annual government statement of ex- penditure under the Plant Genetic Conservation Project Under the Royal Initiative of Her Royal Highness Princess Maha Chakri Sirindhorn RSPG-WU-09/2567
6 · The paper itselfAbstract
This study characterizes the genomic identity, functional efficacy, and computational biophysics of FNL62-AMP, a novel antimicrobial peptide isolated from a phylogenomically distinct, newly identified
Indexed as
Anti-Bacterial AgentsAntimicrobial PeptidesBrevibacillusAquatic OrganismsMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular Dynamics SimulationAnti-Bacterial AgentsAntimicrobial PeptidesAMPantimicrobial peptideantimicrobial resistanceBrevibacillusFNL62genomemolecular dynamics simulationsMRSAself-aggregationStaphylococcus aureus
Identifiers
PMID42783902
PMCPMC13608124
What OpenQuestion holds
Textmetadata
Read underepoch 390